Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-25-000086
Filing Date
2025-08-06
Accepted
2025-08-06 06:09:51
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20250630.htm   iXBRL 10-Q 1043552
2 EX-10.4 ex104directorcompensationp.htm EX-10.4 15293
3 EX-31.1 exhibit311-certificationof.htm EX-31.1 10293
4 EX-31.2 exhibit312-certificationof.htm EX-31.2 10282
5 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6007
  Complete submission text file 0000899923-25-000086.txt   5807835

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20250630.xsd EX-101.SCH 41506
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20250630_cal.xml EX-101.CAL 61355
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20250630_def.xml EX-101.DEF 144088
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20250630_lab.xml EX-101.LAB 560353
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20250630_pre.xml EX-101.PRE 366732
80 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20250630_htm.xml XML 760285
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 251187285
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)